Methodology for biomarker discovery with reproducibility in microbiome data using machine learning.

Area of Science:

• Microbiome research
• Bioinformatics
• Machine learning in healthcare

Background:

• Human microbiome studies are crucial for clinical applications, with machine learning aiding biomarker discovery.
• Challenges in microbiome research include small sample sizes, inconsistent results, and lack of reproducibility.
• Current methods need improvement for robust and reliable biomedical research.

Purpose of the Study:

• To propose a novel methodology for reproducible biomarker discovery in 16S rRNA microbiome sequence analysis.
• To address issues of data dimensionality, inconsistent results, and cross-dataset validation.
• To enhance the reliability and robustness of microbiome biomarker discovery.

Main Methods:

• Combined the DADA2 pipeline for 16S rRNA sequence processing with Recursive Ensemble Feature Selection (REFS).
• Applied the methodology across multiple datasets from Inflammatory Bowel Disease (IBD), Autism Spectrum Disorder (ASD), and Type 2 Diabetes (T2D) cohorts.
• Compared the proposed method against K-Best F-score and random selection using Area Under the Curve (AUC) and Matthews Correlation Coefficient (MCC).

Main Results:

• The proposed methodology demonstrated higher diagnostic accuracy compared to traditional feature selection methods.
• Biomarker signatures were identified in one dataset and successfully validated in others for IBD, ASD, and T2D.
• The approach showed improved performance metrics (AUC and MCC) across nine diverse datasets.

Conclusions:

• A reproducible methodology for microbiome biomarker discovery using 16S rRNA data was successfully developed.
• The findings highlight the methodology's effectiveness in improving accuracy and reliability in biomarker identification.
• This approach represents a significant step towards more robust and reproducible microbiome research for clinical translation.